Loto del Sur has sold a stake in the company to Puig
The private shareholder of Loto del Sur has sold a 55% stake in the company to Puig on a two-stage transaction, with an initial 35% stake. Financial details have not been disclosed.
Cosmetika SAS operates under Loto del Sur, a premium natural cosmetic brand that operates its own stores, at an affordable price. The company was founded in 2001 and opened its first store in 2010. Loto del Sur has seven stores in Colombia. The company had revenues of US$4.7 million in 2018.
Puig is a Spanish family-owned company that engages in the fashion and fragrance business. The company operates under their own brands, including Nina Ricci, Carolina Herrera, Jean Paul Gautier, Paco Rabanne, Penhaligon’s and L’Artisan Parfumer, as well as licenses such as Prada, Christian Louboutin and Comme des Garçons, among others. Puig has five production plants, four in Europe and one in Mexico, and commercializes its products in 150 countries. In 2017, Puig had revenues of US$2.2 billion with US$258 million net income.
Oaklins’ team in Colombia acted as the exclusive advisor to the seller in this transaction.


Talk to the deal team
Related deals
Ambala Foods Limited has been acquired by Cake Box Holdings plc
Cake Box Holdings plc has acquired the Asian dessert specialist Ambala Foods Limited.
Learn moreOBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreWeinberg Capital Partners has acquired Cosmogen
Weinberg Capital Partners has acquired a majority stake in Cosmogen, a leading expert in primary packaging for the beauty industry, from MBO+. This transaction will strengthen Weinberg Capital Partners’ presence in the beauty sector and drive a new phase of growth for Cosmogen.
Learn more